Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS

NCT06367881 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Neonatal Respiratory Distress Syndrome
Inflammatory Response
Premature Lungs
Neutrophil Extracellular Trap Formation
Preterm Birth

Interventions

DRUG: Alveofact
DRUG: Budesonide

Sponsor

Ain Shams University